Homepage | Annals of the Rheumatic Diseases
2 days ago · The homepage of Annals of the Rheumatic Diseases, a leading rheumatology journal published by BMJ and EULAR.
Home | Annals of the Rheumatic Diseases
Oct 11, 2024 · Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education.
Authors - Annals of the Rheumatic Diseases
BMJ is committed to ensuring that all good quality research is published. Our article transfer service helps authors find the best journal for their research while providing an easy and …
EULAR recommendations for the management of rheumatoid …
Objectives To provide an update of the EULAR rheumatoid arthritis (RA) management recommendations addressing the most recent developments in the field. Methods An …
Online First - Annals of the Rheumatic Diseases
Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, …
About - Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of …
Therapeutic interception in individuals at risk of rheumatoid …
Sep 23, 2024 · Multiple clinical trials for rheumatoid arthritis (RA) prevention have been completed. Here, we set out to report on the lessons learnt from these studies. Researchers …
Safety of synthetic and biological DMARDs: a systematic literature ...
Objectives To perform a systematic literature review (SLR) concerning the safety of synthetic (s) and biological (b) disease-modifying anti rheumatic dugs (DMARDs) to inform the 2019 update …
Top cited articles - Annals of the Rheumatic Diseases
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update ASAS-EULAR recommendations for the …
Efficacy of synthetic and biological DMARDs: a systematic …
Jan 14, 2022 · Objectives To update the evidence on efficacy of DMARDs (disease-modifying antirheumatic drugs) and inform the taskforce of the 2022 update of the European Alliance of …